Journal of Leukemia
Open Access
ISSN: 2329-6917
+44 1300 500008
ISSN: 2329-6917
+44 1300 500008
Department of Clinical Pharmacy, King Faisal University, Dammam, Saudi Arabia
Research Article
Evaluation of the Clinical Outcomes among the Pediatric Low-Risk Acute Myeloid Leukemia Patients Who Received Four versus Five Cycles of Chemotherapy-Single-Center Study
Author(s): Abeer AL-Amer, Hala Omer, Eyad Saad, Omyma Ahmed and Saad AL Daama*
Objectives: The Primary objective of this study is to compare the Overall Survival (OS), Event Free Survival (EFS), and Relapse Risk (RR) for Low Risk/Intermediate Risk (LR/IR) patients receiving four versus five chemotherapy
courses as per MRC 15 chemotherapy protocol and to assess the therapy-associated toxicity and complications of
therapy in both cohort arms. The secondary objective is to compere the cost and patients’ length of hospital stay
in both cohorts, 4 versus 5 cycles patients.
Design: This is a retrospective descriptive study. It includes all patient’s less 16 year diagnosed with acute myeloid
leukemia, non-high risk and treated with chemotherapy alone without allogeneic stem cell transplantation at King
Fahad Specialist Hospital Dammam, Dammam (KFSHD), pediatric, hematology/onc.. View More»
DOI:
10.35248/2329-6917.23.11.352